{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:21:23Z","timestamp":1772252483437,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Basic Research Fund, First Affiliated Hospital of Gannan Medical University","award":["QD095"],"award-info":[{"award-number":["QD095"]}]},{"name":"The Basic Research Fund, First Affiliated Hospital of Gannan Medical University","award":["QD095"],"award-info":[{"award-number":["QD095"]}]},{"name":"The Basic Research Fund, First Affiliated Hospital of Gannan Medical University","award":["QD095"],"award-info":[{"award-number":["QD095"]}]},{"name":"The Basic Research Fund, First Affiliated Hospital of Gannan Medical University","award":["QD095"],"award-info":[{"award-number":["QD095"]}]},{"name":"Xuzhou Key Research and Development Program under Grant","award":["KC23273"],"award-info":[{"award-number":["KC23273"]}]},{"name":"Xuzhou Key Research and Development Program under Grant","award":["KC23273"],"award-info":[{"award-number":["KC23273"]}]},{"name":"The Opening Project of Jiangsu Key Laboratory of Xuzhou Medical University","award":["XZSYSKF2021030"],"award-info":[{"award-number":["XZSYSKF2021030"]}]},{"name":"The Opening Project of Jiangsu Key Laboratory of Xuzhou Medical University","award":["XZSYSKF2021030"],"award-info":[{"award-number":["XZSYSKF2021030"]}]},{"name":"Hospitallevel Scientific Research Project of Affiliated Hospital of Xuzhou Medical University","award":["2022ZL26"],"award-info":[{"award-number":["2022ZL26"]}]},{"name":"Hospitallevel Scientific Research Project of Affiliated Hospital of Xuzhou Medical University","award":["2022ZL26"],"award-info":[{"award-number":["2022ZL26"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Diabetic retinopathy (DR), a prevalent complication in patients with type 2 diabetes, has attracted increasing attention. Recent studies have explored a plausible association between retinopathy and significant liver fibrosis. The aim of this investigation was to develop a sophisticated machine learning (ML) model, leveraging comprehensive clinical datasets, to forecast the likelihood of significant liver fibrosis in patients with retinopathy and to interpret the ML model by applying the SHapley Additive exPlanations (SHAP) method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This inquiry was based on data from the National Health and Nutrition Examination Survey 2005\u20132008 cohort. Utilizing the Fibrosis-4 index (FIB-4), liver fibrosis was stratified across a spectrum of grades (F0-F4). The severity of retinopathy was determined using retinal imaging and segmented into four discrete gradations. A ten-fold cross-validation approach was used to gauge the propensity towards liver fibrosis. Eight ML methodologies were used: Extreme Gradient Boosting, Random Forest, multilayer perceptron, Support Vector Machines, Logistic Regression (LR), Plain Bayes, Decision Tree, and k-nearest neighbors. The efficacy of these models was gauged using metrics, such as the area under the curve (AUC). The SHAP method was deployed to unravel the intricacies of feature importance and explicate the inner workings of the ML model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The analysis included 5,364 participants, of whom 2,116 (39.45%) exhibited notable liver fibrosis. Following random allocation, 3,754 individuals were assigned to the training set and 1,610 were allocated to the validation cohort. Nine variables were curated for integration into the ML model. Among the eight ML models scrutinized, the LR model attained zenith in both AUC (0.867, 95% CI: 0.855\u20130.878) and F1 score (0.749, 95% CI: 0.732\u20130.767). In internal validation, this model sustained its superiority, with an AUC of 0.850 and an F1 score of 0.736, surpassing all other ML models. The SHAP methodology unveils the foremost factors through importance ranking.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Sophisticated ML models were crafted using clinical data to discern the propensity for significant liver fibrosis in patients with retinopathy and to intervene early.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Practice implications<\/jats:title>\n                <jats:p>Improved early detection of liver fibrosis risk in retinopathy patients enhances clinical intervention outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12911-024-02749-z","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T09:28:53Z","timestamp":1731317333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Explainable machine learning model for predicting the risk of significant liver fibrosis in patients with diabetic retinopathy"],"prefix":"10.1186","volume":"24","author":[{"given":"Gangfeng","family":"Zhu","sequence":"first","affiliation":[]},{"given":"Na","family":"Yang","sequence":"additional","affiliation":[]},{"given":"Qiang","family":"Yi","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Xu","sequence":"additional","affiliation":[]},{"given":"Liangjian","family":"Zheng","sequence":"additional","affiliation":[]},{"given":"Yunlong","family":"Zhu","sequence":"additional","affiliation":[]},{"given":"Junyan","family":"Li","sequence":"additional","affiliation":[]},{"given":"Jie","family":"Che","sequence":"additional","affiliation":[]},{"given":"Cixiang","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Zenghong","family":"Lu","sequence":"additional","affiliation":[]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[]},{"given":"Yi","family":"Xiang","sequence":"additional","affiliation":[]},{"given":"Tianlei","family":"Zheng","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"issue":"1","key":"2749_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151\u201371.","journal-title":"J Hepatol"},{"issue":"10036","key":"2749_CR2","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/S0140-6736(16)00648-6","volume":"387","author":"AH Mokdad","year":"2016","unstructured":"Mokdad AH, Forouzanfar MH, Daoud F, Mokdad AA, El Bcheraoui C, Moradi-Lakeh M, et al. Global burden of diseases, injuries, and risk factors for young people\u2019s health during 1990\u20132013: a systematic analysis for the global burden of disease study 2013. Lancet. 2016;387(10036):2383\u2013401.","journal-title":"Lancet"},{"issue":"10258","key":"2749_CR3","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"key":"2749_CR4","doi-asserted-by":"publisher","first-page":"1277808","DOI":"10.3389\/fimmu.2023.1277808","volume":"14","author":"M Casari","year":"2023","unstructured":"Casari M, Siegl D, Deppermann C, Schuppan D. Macrophages and platelets in liver fibrosis and hepatocellular carcinoma. Front Immunol. 2023;14:1277808.","journal-title":"Front Immunol"},{"issue":"23","key":"2749_CR5","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","volume":"20","author":"WC Zhou","year":"2014","unstructured":"Zhou WC, Zhang QB, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol. 2014;20(23):7312\u201324.","journal-title":"World J Gastroenterol"},{"key":"2749_CR6","doi-asserted-by":"crossref","unstructured":"Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020;9(4).","DOI":"10.3390\/cells9040875"},{"key":"2749_CR7","doi-asserted-by":"crossref","unstructured":"Caligiuri A, Gentilini A, Pastore M, Gitto S, Marra F. Cellular and molecular mechanisms underlying liver fibrosis regression. Cells. 2021;10(10).","DOI":"10.3390\/cells10102759"},{"issue":"8","key":"2749_CR8","doi-asserted-by":"publisher","first-page":"728","DOI":"10.21037\/atm-20-2948","volume":"9","author":"A Khurana","year":"2021","unstructured":"Khurana A, Sayed N, Allawadhi P, Weiskirchen R. It\u2019s all about the spaces between cells: role of extracellular matrix in liver fibrosis. Ann Transl Med. 2021;9(8):728.","journal-title":"Ann Transl Med"},{"issue":"Suppl1","key":"2749_CR9","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.jhep.2004.12.008","volume":"42","author":"M Pinzani","year":"2005","unstructured":"Pinzani M, Rombouts K, Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol. 2005;42(Suppl1):S22\u201336.","journal-title":"J Hepatol"},{"issue":"6","key":"2749_CR10","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","volume":"158","author":"RS Taylor","year":"2020","unstructured":"Taylor RS, Taylor RJ, Bayliss S, Hagstr\u00f6m H, Nasr P, Schattenberg JM, et al. Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Gastroenterology. 2020;158(6):1611\u201325. e12.","journal-title":"Gastroenterology"},{"issue":"2","key":"2749_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389\u201397. e10.","journal-title":"Gastroenterology"},{"issue":"12","key":"2749_CR12","doi-asserted-by":"publisher","first-page":"694","DOI":"10.12968\/hmed.2018.79.12.694","volume":"79","author":"JW Day","year":"2018","unstructured":"Day JW, Rosenberg WM. The enhanced liver fibrosis (ELF) test in diagnosis and management of liver fibrosis. Br J Hosp Med (London England: 2005). 2018;79(12):694\u20139.","journal-title":"Br J Hosp Med (London England: 2005)"},{"issue":"5","key":"2749_CR13","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/liv.15555","volume":"43","author":"M Kugelmas","year":"2023","unstructured":"Kugelmas M, Noureddin M, Gunn N, Brown K, Younossi Z, Abdelmalek M, et al. The use of current knowledge and non-invasive testing modalities for predicting at-risk non-alcoholic steatohepatitis and assessing fibrosis. Liver Int. 2023;43(5):964\u201374.","journal-title":"Liver Int"},{"issue":"13","key":"2749_CR14","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1080\/14656566.2020.1774553","volume":"21","author":"J Lambrecht","year":"2020","unstructured":"Lambrecht J, van Grunsven LA, Tacke F. Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosis. Expert Opin Pharmacother. 2020;21(13):1637\u201350.","journal-title":"Expert Opin Pharmacother"},{"issue":"45","key":"2749_CR15","doi-asserted-by":"publisher","first-page":"16820","DOI":"10.3748\/wjg.v20.i45.16820","volume":"20","author":"S Sharma","year":"2014","unstructured":"Sharma S, Khalili K, Nguyen GC. Non-invasive diagnosis of advanced fibrosis and cirrhosis. World J Gastroenterol. 2014;20(45):16820\u201330.","journal-title":"World J Gastroenterol"},{"key":"2749_CR16","doi-asserted-by":"crossref","unstructured":"Honda Y, Yoneda M, Imajo K, Nakajima A. Elastography techniques for the assessment of liver fibrosis in non-alcoholic fatty liver disease. Int J Mol Sci. 2020;21(11).","DOI":"10.3390\/ijms21114039"},{"issue":"1","key":"2749_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","volume":"63","author":"EASL-ALEH Clinical Practice Guidelines","year":"2015","unstructured":"EASL-ALEH Clinical Practice Guidelines. Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63(1):237\u201364.","journal-title":"J Hepatol"},{"issue":"7","key":"2749_CR18","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1136\/gut.2010.221382","volume":"60","author":"D Roulot","year":"2011","unstructured":"Roulot D, Costes JL, Buyck JF, Warzocha U, Gambier N, Czernichow S, et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut. 2011;60(7):977\u201384.","journal-title":"Gut"},{"issue":"7","key":"2749_CR19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nrgastro.2016.86","volume":"13","author":"M Friedrich-Rust","year":"2016","unstructured":"Friedrich-Rust M, Poynard T, Castera L. Critical comparison of elastography methods to assess chronic liver disease. Nat Rev Gastroenterol Hepatol. 2016;13(7):402\u201311.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5\u20136","key":"2749_CR20","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.biocel.2005.08.002","volume":"38","author":"JL Wilkinson-Berka","year":"2006","unstructured":"Wilkinson-Berka JL. Angiotensin and diabetic retinopathy. Int J Biochem Cell Biol. 2006;38(5\u20136):752\u201365.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"2749_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S2213-8587(19)30411-5","volume":"8","author":"S Vujosevic","year":"2020","unstructured":"Vujosevic S, Aldington SJ, Silva P, Hern\u00e1ndez C, Scanlon P, Peto T, et al. Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol. 2020;8(4):337\u201347.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2749_CR22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556\u201364.","journal-title":"Diabetes Care"},{"issue":"1","key":"2749_CR23","doi-asserted-by":"publisher","first-page":"010803","DOI":"10.7189\/jogh.08.010803","volume":"8","author":"P Song","year":"2018","unstructured":"Song P, Yu J, Chan KY, Theodoratou E, Rudan I. Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis. J Glob Health. 2018;8(1):010803.","journal-title":"J Glob Health"},{"issue":"5","key":"2749_CR24","first-page":"75","volume":"107","author":"AN Kollias","year":"2010","unstructured":"Kollias AN, Ulbig MW. Diabetic retinopathy: early diagnosis and effective treatment. Dtsch Arztebl Int. 2010;107(5):75\u201383. quiz 4.","journal-title":"Dtsch Arztebl Int"},{"key":"2749_CR25","doi-asserted-by":"publisher","first-page":"1019899","DOI":"10.3389\/fmolb.2022.1019899","volume":"9","author":"GH Zhang","year":"2022","unstructured":"Zhang GH, Yuan TH, Yue ZS, Wang L, Dou GR. The presence of diabetic retinopathy closely associated with the progression of non-alcoholic fatty liver disease: a meta-analysis of observational studies. Front Mol Biosci. 2022;9:1019899.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"2749_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41598-023-50582-7","volume":"14","author":"KH Kang","year":"2024","unstructured":"Kang KH, Shin D, Ryu IH, Kim JK, Lee IS, Koh K, et al. Association between cataract and fatty liver diseases from a nationwide cross-sectional study in South Korea. Sci Rep. 2024;14(1):77.","journal-title":"Sci Rep"},{"key":"2749_CR27","doi-asserted-by":"publisher","first-page":"102424","DOI":"10.1016\/j.eclinm.2024.102424","volume":"68","author":"C Chen","year":"2024","unstructured":"Chen C, Wei L, He W, Zhang Y, Xiao J, Lu Y, et al. Associations of severe liver diseases with cataract using data from UK Biobank: a prospective cohort study. EClinicalMedicine. 2024;68:102424.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"2749_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10792-024-03103-y","volume":"44","author":"R Patel","year":"2024","unstructured":"Patel R, Nair S, Choudhry H, Jaffry M, Dastjerdi M. Ocular manifestations of liver disease: an important diagnostic aid. Int Ophthalmol. 2024;44(1):177.","journal-title":"Int Ophthalmol"},{"key":"2749_CR29","doi-asserted-by":"publisher","first-page":"823277","DOI":"10.3389\/fmolb.2021.823277","volume":"8","author":"TH Yuan","year":"2021","unstructured":"Yuan TH, Yue ZS, Zhang GH, Wang L, Dou GR. Beyond the liver: liver-eye communication in clinical and experimental aspects. Front Mol Biosci. 2021;8:823277.","journal-title":"Front Mol Biosci"},{"issue":"12","key":"2749_CR30","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S. Nonalcoholic steatohepatitis: a review. JAMA. 2020;323(12):1175\u201383.","journal-title":"JAMA"},{"issue":"11","key":"2749_CR31","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1002\/jcb.25575","volume":"117","author":"M Capit\u00e3o","year":"2016","unstructured":"Capit\u00e3o M, Soares R. Angiogenesis and inflammation crosstalk in diabetic retinopathy. J Cell Biochem. 2016;117(11):2443\u201353.","journal-title":"J Cell Biochem"},{"key":"2749_CR32","doi-asserted-by":"crossref","unstructured":"Maru\u0161i\u0107 M, Pai\u0107 M, Knobloch M, Liberati Pr\u0161o A-M. NAFLD, insulin resistance, and diabetes mellitus type 2. Can J Gastroenterol Hepatol. 2021;2021.","DOI":"10.1155\/2021\/6613827"},{"issue":"4","key":"2749_CR33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/01.mol.0000174153.53683.f2","volume":"16","author":"G Marchesini","year":"2005","unstructured":"Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol. 2005;16(4):421\u20137.","journal-title":"Curr Opin Lipidol"},{"key":"2749_CR34","first-page":"S17","volume":"40","author":"AJ McCullough","year":"2006","unstructured":"McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol. 2006;40:S17\u201329.","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"2749_CR35","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615\u201325.","journal-title":"Diabetes"},{"issue":"2","key":"2749_CR36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/ncpendmet0046","volume":"1","author":"PH Groop","year":"2005","unstructured":"Groop PH, Forsblom C, Thomas MC. Mechanisms of disease: pathway-selective insulin resistance and microvascular complications of diabetes. Nat Clin Pract Endocrinol Metab. 2005;1(2):100\u201310.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"2","key":"2749_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrendo.2017.173","volume":"14","author":"G Targher","year":"2018","unstructured":"Targher G, Lonardo A, Byrne CD. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nat Rev Endocrinol. 2018;14(2):99\u2013114.","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"2749_CR38","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","volume":"110","author":"CP Wilkinson","year":"2003","unstructured":"Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677\u201382.","journal-title":"Ophthalmology"},{"issue":"10","key":"2749_CR39","doi-asserted-by":"publisher","first-page":"e006556","DOI":"10.1161\/CIRCOUTCOMES.120.006556","volume":"13","author":"LM Stevens","year":"2020","unstructured":"Stevens LM, Mortazavi BJ, Deo RC, Curtis L, Kao DP. Recommendations for reporting machine learning analyses in clinical research. Circ Cardiovasc Qual Outcomes. 2020;13(10):e006556.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"2749_CR40","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/jcsm.13176","volume":"14","author":"H Chung","year":"2023","unstructured":"Chung H, Ko Y, Lee IS, Hur H, Huh J, Han SU, et al. Prognostic artificial intelligence model to predict 5 year survival at 1 year after gastric cancer surgery based on nutrition and body morphometry. J Cachexia Sarcopenia Muscle. 2023;14(2):847\u201359.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"2749_CR41","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.clnu.2021.11.006","volume":"41","author":"H Shi","year":"2022","unstructured":"Shi H, Yang D, Tang K, Hu C, Li L, Zhang L, et al. Explainable machine learning model for predicting the occurrence of postoperative malnutrition in children with congenital heart disease. Clin Nutr. 2022;41(1):202\u201310.","journal-title":"Clin Nutr"},{"issue":"6","key":"2749_CR42","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/joim.12822","volume":"284","author":"GS Handelman","year":"2018","unstructured":"Handelman GS, Kok HK, Chandra RV, Razavi AH, Lee MJ, Asadi H. eDoctor: machine learning and the future of medicine. J Intern Med. 2018;284(6):603\u201319.","journal-title":"J Intern Med"},{"issue":"1","key":"2749_CR43","first-page":"44","volume":"8","author":"WT Wu","year":"2021","unstructured":"Wu WT, Li YJ, Feng AZ, Li L, Huang T, Xu AD, et al. Data mining in clinical big data: the frequently used databases, steps, and methodological models. Mil Med Res. 2021;8(1):44.","journal-title":"Mil Med Res"},{"issue":"2","key":"2749_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology (Baltimore MD). 1996;24(2):289\u201393.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"4","key":"2749_CR45","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/hep.29285","volume":"66","author":"KA So-Armah","year":"2017","unstructured":"So-Armah KA, Lim JK, Lo Re V, Tate JP, Chang CH, Butt AA, et al. FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patients. Hepatology (Baltimore MD). 2017;66(4):1286\u201395.","journal-title":"Hepatology (Baltimore MD)"},{"key":"2749_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i11","volume":"36","author":"MB Kursa","year":"2010","unstructured":"Kursa MB, Rudnicki WR. Feature selection with the Boruta package. J Stat Softw. 2010;36:1\u201313.","journal-title":"J Stat Softw"},{"issue":"2","key":"2749_CR47","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/bib\/bbx124","volume":"20","author":"F Degenhardt","year":"2019","unstructured":"Degenhardt F, Seifert S, Szymczak S. Evaluation of variable selection methods for random forests and omics data sets. Brief Bioinform. 2019;20(2):492\u2013503.","journal-title":"Brief Bioinform"},{"key":"2749_CR48","unstructured":"Lundberg S. A unified approach to interpreting model predictions. arXiv Preprint. 2017;arXiv:170507874."},{"key":"2749_CR49","unstructured":"Bekkar M, Djemaa HK, Alitouche TA. Evaluation measures for models assessment over imbalanced data sets. 2013."},{"issue":"4","key":"2749_CR50","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ipm.2009.03.002","volume":"45","author":"M Sokolova","year":"2009","unstructured":"Sokolova M, Lapalme G. A systematic analysis of performance measures for classification tasks. Inf Process Manag. 2009;45(4):427\u201337.","journal-title":"Inf Process Manag"},{"issue":"10","key":"2749_CR51","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrendo.2016.105","volume":"12","author":"P Zimmet","year":"2016","unstructured":"Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Reviews Endocrinol. 2016;12(10):616\u201322.","journal-title":"Nat Reviews Endocrinol"},{"issue":"6","key":"2749_CR52","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S2213-8587(16)30010-9","volume":"4","author":"EW Gregg","year":"2016","unstructured":"Gregg EW, Sattar N, Ali MK. The changing face of diabetes complications. Lancet Diabetes Endocrinol. 2016;4(6):537\u201347.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"2749_CR53","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.cgh.2017.12.048","volume":"16","author":"L Caballer\u00eda","year":"2018","unstructured":"Caballer\u00eda L, Pera G, Arteaga I, Rodr\u00edguez L, Alum\u00e0 A, Morillas RM, et al. High prevalence of liver fibrosis among European adults with unknown liver disease: a population-based study. Clin Gastroenterol Hepatol. 2018;16(7):1138\u201345. e5.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"2749_CR54","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","volume":"142","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142(7):1592\u2013609.","journal-title":"Gastroenterology"},{"issue":"1","key":"2749_CR55","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the study of Liver diseases. Hepatology (Baltimore MD). 2018;67(1):328\u201357.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"1","key":"2749_CR56","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore MD). 2016;64(1):73\u201384.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"2","key":"2749_CR57","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s12072-015-9607-3","volume":"9","author":"W Yang","year":"2015","unstructured":"Yang W, Xu H, Yu X, Wang Y. Association between retinal artery lesions and nonalcoholic fatty liver disease. Hepatol Int. 2015;9(2):278\u201382.","journal-title":"Hepatol Int"},{"key":"2749_CR58","doi-asserted-by":"publisher","first-page":"175628481985847","DOI":"10.1177\/1756284819858470","volume":"12","author":"M Mouzaki","year":"2019","unstructured":"Mouzaki M, Loomba R. Insights into the evolving role of the gut microbiome in nonalcoholic fatty liver disease: rationale and prospects for therapeutic intervention. Th Adv Gastroenterol. 2019;12:1756284819858470.","journal-title":"Th Adv Gastroenterol"},{"issue":"2","key":"2749_CR59","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00592-020-01610-9","volume":"58","author":"W Liu","year":"2021","unstructured":"Liu W, Wang C, Xia Y, Xia W, Liu G, Ren C, et al. Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy. Acta Diabetol. 2021;58(2):221\u20139.","journal-title":"Acta Diabetol"},{"issue":"1","key":"2749_CR60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology (Baltimore MD). 2007;46(1):32\u20136.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"6","key":"2749_CR61","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology (Baltimore MD). 2006;43(6):1317\u201325.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"2","key":"2749_CR62","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","volume":"128","author":"L Cast\u00e9ra","year":"2005","unstructured":"Cast\u00e9ra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128(2):343\u201350.","journal-title":"Gastroenterology"},{"issue":"5","key":"2749_CR63","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","volume":"71","author":"FE M\u00f3zes","year":"2022","unstructured":"M\u00f3zes FE, Lee JA, Selvaraj EA, Jayaswal ANA, Trauner M, Boursier J, et al. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut. 2022;71(5):1006\u201319.","journal-title":"Gut"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-024-02749-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-024-02749-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-024-02749-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T02:03:17Z","timestamp":1731376997000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-024-02749-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2749"],"URL":"https:\/\/doi.org\/10.1186\/s12911-024-02749-z","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"25 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical review and approval was not required for the study on human participants in accordance with the local legislation and institutional requirements. The patients\/participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}